查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
裂肛治療藥的全球市場(2022年～2029年)
市場調查報告書
商品編碼
1082819

裂肛治療藥的全球市場(2022年～2029年)

Global Anal Fissure Therapeutics Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 190 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

本報告提供全球裂肛治療藥市場相關調查分析，市場趨勢，推動及阻礙市場要素，COVID-19影響，產業分析，各市場區隔、各地區的市場分析，競爭情形，企業簡介等資訊。

目錄

第1章 全球裂肛治療藥市場調查手法和範圍

第2章 全球裂肛治療藥市場:市場定義和概要

第3章 全球裂肛治療藥市場:摘要整理

  • 各治療的市場明細
  • 各給藥途徑的市場明細
  • 流通管道市場明細
  • 各地區的市場明細

第4章 全球裂肛治療藥市場:市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球裂肛治療藥市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 法規分析

第6章 全球裂肛治療藥市場:COVID-19分析

  • 市場的COVID-19影響分析
    • COVID-19前的市場情境
    • COVID-19目前市場情境
    • COVID-19後，以及未來情境
  • COVID-19疫情中的價格動態
  • 需求與供給的頻譜
  • 大流行時的市場相關的政府的配合措施
  • 製造商策略性配合措施
  • 結論

第7章 全球裂肛治療藥市場:各治療

  • 簡介
    • 市場規模分析、與前一年同期比較成長分析(%):各治療
    • 市場魅力指數:各治療
  • 硝酸鹽軟膏
    • 簡介
    • 市場規模分析(2020年～2029年)、與前一年同期比較成長分析(2021年～2029年)
  • 鈣離子通道阻斷劑
  • 肉毒桿菌注射
  • 其他

第8章 全球裂肛治療藥市場:各給藥途徑

  • 簡介
    • 市場規模分析、與前一年同期比較成長分析(%):各給藥途徑
    • 市場魅力指數:各給藥途徑
  • 口服
    • 簡介
    • 市場規模分析(2020年～2029年)、與前一年同期比較成長分析(2021年～2029年)
  • 局部
  • 其他

第9章 全球裂肛治療藥市場:各流通管道

  • 簡介
    • 市場規模分析、與前一年同期比較成長分析(%):各流通管道
    • 市場魅力指數:各流通管道
  • 醫院藥局
    • 簡介
    • 市場規模分析(2020年～2029年)、與前一年同期比較成長分析(2021年～2029年)
  • 線上藥局
  • 零售藥局

第10章 全球裂肛治療藥市場:各地區

  • 簡介
    • 市場規模分析(2020年～2029年)、與前一年同期比較成長分析(2021年～2029年):各地區
    • 市場魅力指數:各地區
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東、非洲

第11章 全球裂肛治療藥市場:競爭情形

  • 主要的發展與策略
  • 企業佔有率分析
  • 產品的基準

第12章 全球裂肛治療藥市場:企業簡介

  • Takeda Pharmaceuticals
    • 企業概要
    • 產品介紹、說明
    • 主要亮點
    • 財務概要
  • Manus Aktteva
  • Pfizer
  • AbbVie
  • Farmacosmo
  • Silvergate Pharmaceuticals
  • Covis Pharmaceuticals
  • Novartis AG
  • Trumachealthcare
  • Taj Pharmaceuticals

第13章 全球裂肛治療藥市場:DataM

簡介目錄
Product Code: DMHCIT5266

Market Overview

The global anal fissure therapeutics market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

An anorectal condition marked by inflammation or tearing of the lining of the lower rectum is known as an anal fissure. During bowel movements, it causes considerable discomfort and blood. The ailment is not life-threatening, but it has a major impact on a person's quality of life.

Market Dynamics

The factors driving the growth of the anal fissure treatment market include increasing cases of of constipation, growing adoption of a sedentary lifestyle, and consumption of spicy, saturated, and trans-fat foods. Furthermore, the advent of novel treatments and increased awareness of anorectal illnesses are factors influencing the growth of this market.

Rising cases of aquired immunodeficiency syndrome will drive the market growth

Growing awareness of various treatment choices, advancements in medications and surgical processes like laser therapy, and a reduction in the social stigma associated with its treatment contribute to the market's expansion. Rising TB cases, cancer, an acquired immunodeficiency syndrome (AIDS), and inflammatory bowel disease. Furthermore, hormonal changes in pregnant women promote constipation, which leads to anal fissures. Anal fissures can also be caused by childbirth stress. Other risk factors include anal sex, ulcerative colitis, and Crohn's disease.

According to UNAIDS, In 2020, there will be roughly 37.7 million HIV-positive people worldwide. There were 36 million adults and 1.7 million children aged 0-14 years. More than half (53%) were females and girls.Moreover, In 2015, an estimated 1.3 percent of adults in the United States (3 million) were diagnosed with IBD (either Crohn's disease or ulcerative colitis). This was a significant rise over 1999. (0.9 percent or 2 million adults).(Source: Centre for Disease Control and Prevention).

Moreover, Constipation is common among Americans. Constipation affects almost everyone at some point in their lives, with a recent poll revealing that 16% of Americans and one-third of those over 60 suffer from chronic constipation.(Source:Statnews). These factors are likely to boost the anal fissure therapeutics market.

Harmful effects of medications is likely to hamper the market growth

Nonetheless, the harmful effects of medications like headaches, dizziness, itching, or burning at and the increased rate of treatment-seeking are the factors impeding the growth of this market.

COVID-19 Impact Analysis

The global market for anal fissure therapeutics has been impacted due to COVID-19 outbreak. The pandemic has hampered progress in several countries across multiple disciplines. The COVID-19 outbreak continued to harm important major participants in the anal fissure treatment industry. However, many producers are struggling due to supply chain delays caused by lockdown in various nations in the third quarter. However, the negative impact is being partially compensated in several ways, such as utilizing numerous distribution alternatives and online channels.

Segment Analysis

The calcium channel blockers segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

By treatment, the market is divided into nitrate ointment, calcium channel blockers, botox injections and others. Calcium channel blockers are going to boost in the forecast period.Calcium channel blockers are antihypertensive medicines. They function by blocking calcium from entering the heart and artery cells. Calcium causes the heart and arteries to constrict more tightly. Calcium channel blockers allow blood arteries to relax and open by inhibiting calcium. Infants and middle-aged people are the most commonly affected by anal fissures. Every year, around 235,000 new cases of an anal fissure are reported in the United States.(Source: Uptodate).

Geographical Analysis

North America region holds the largest market share of the global anal fissure therapeutics market

The North American anal fissure therapeutics market accounted for the maximum share because of the widespread use of advanced treatment. Another significant market driver is the high rate of blockage among patients. According to the American Gastroenterological Association, about 60% of Americans suffer from this illness. Medicines required for rapid recovery are likely to accelerate the growth of the anal fissure treatment market.

North American region is developing novel treatment alternatives. Furthermore, rising death rates increased patient awareness about the disease. Advanced healthcare infrastructure is expected to drive the growth of the anal fissure therapeutics market in North America.

Competitive Landscape

The anal fissure therapeutics market is a highly competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Takeda Pharmaceuticals, Manus Aktteva, Pfizer, AbbVie, Pfizer, Farmacosmo, Silvergate Pharmaceuticals, Covis Pharmaceuticals, Novartis AG, Trumachealthcare, Taj Pharmaceuticals, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the anal fissure therapeutics market globally. For instance, in Februray 2021, Takeda Files New Drug Application in Japan to Manufacture and Market Darvadstrocel for the Treatment of Complex Perianal Fistulas in Adult Crohn's Disease Patients

Taj Pharmaceuticals Limited

Overview:

Taj Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells medications. Prescription solutions, lifesaving pharmaceuticals, anti-cancer drugs, veterinary products, consumer brands, and CNS drugs are among the company's offerings. It focuses on anemia, anxiety disorders, cancer/oncology, ear infections, heart failure, hepatitis, HIV/AIDS, influenza, non-lymphoma, Hodgkin's obesity, osteoporosis, Parkinson's disease, pneumonia, transplantation, and widespread diseases. The Taj Pharmaceuticals India Business is based in Mumbai, India.

Product Portfolio:

Nitroglycerin ointment: Nitroglycerin ointment is an excellent treatment for anal fissure because many patients prefer to forgo surgery; Glyceryl trinitrate topical treatment has been shown in studies to reduce maximum anal resting pressures in patients with a range of anal pathologies. As a result, anal fissure repair occurs in many patients than in the control group.

Why Purchase the Report?

Visualize the composition of the global anal fissure therapeutics market segmentation by treatment, route of administration, distribution channel, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global anal fissure therapeutics market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global anal fissure therapeutics market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global anal fissure therapeutics market report would provide access to an approximately 40+ market data table, 45+ figures, and in the range of 190 (approximate) pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Anal Fissure Therapeutics Market- By Treatment

Nitrate Ointment

Calcium Channel Blockers

Botox Injections

Others

Global Anal Fissure Therapeutics Market- By Route of Administration

Oral

Topical

Others

Global Anal Fissure Therapeutics Market- By Distribution Channel

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Global Anal Fissure Therapeutics Market- By Region

North America

Europe

Asia-Pacific

Middle East & Africa

South America

Table of Contents

1. Global Anal Fissure Therapeutics Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Anal Fissure Therapeutics Market-Market Definition and Overview

3. Global Anal Fissure Therapeutics Market- Executive Summary

  • 3.1. Market Snippet By Treatment
  • 3.2. Market snippet By Route of Administration
  • 3.3. Market snippet By Distribution Channel
  • 3.4. Market Snippet by Region

4. Global Anal Fissure Therapeutics Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Emergence of novel treatment
      • 4.1.1.2. Increasing adoption of sedentary lifestyle
    • 4.1.2. Restraints:
      • 4.1.2.1. Side effects of medications.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Anal Fissure Therapeutics Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. Global Anal Fissure Therapeutics Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Anal Fissure Therapeutics Market- By Treatment

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Segment
    • 7.1.2. Market Attractiveness Index, By Treatment Segment
  • 7.2. Nitrate Ointment*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Calcium Channel Blockers
  • 7.4. Botox Injections
  • 7.5. Others

8. Global Anal Fissure Therapeutics Market- By Route of Administration

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 8.1.2. Market Attractiveness Index, By Route of Administration
  • 8.2. Oral*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Topical
  • 8.4. Others

9. Global Anal Fissure Therapeutics Market- By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Hospital Pharmacy*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Online Pharmacy
  • 9.4. Retail Pharmacy

10. Global Anal Fissure Therapeutics Market- By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Global Anal Fissure Therapeutics Market- Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Global Anal Fissure Therapeutics Market- Company Profiles

  • 12.1. Takeda Pharmaceuticals*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Manus Aktteva
  • 12.3. Pfizer
  • 12.4. AbbVie
  • 12.5. Farmacosmo
  • 12.6. Silvergate Pharmaceuticals
  • 12.7. Covis Pharmaceuticals
  • 12.8. Novartis AG
  • 12.9. Trumachealthcare
  • 12.10. Taj Pharmaceuticals

LIST NOT EXHAUSTIVE

13. Global Anal Fissure Therapeutics Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us